Roundhill GLP-1 & Weight Loss ETF
OZEM
#3019
ETF rank
C$81.54 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$43.61
Share price
-0.24%
Change (1 day)
20.82%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of September 16, 2026Number of holdings: 27

Full holdings list

Weight %NameTickerShares Held
12.51%
Eli Lilly & CoLLY6402
11.97%
Novo Nordisk A/SNVO163734
7.61%
Pfizer IncPFE160549
6.90%
CSPC Pharmaceutical Group Ltd1093 HK3620000
5.18%
Hanmi Pharm Co Ltd128940 KS8245
4.68%
Viking Therapeutics IncVKTX90906
4.23%
Chugai Pharmaceutical Co Ltd4519 JP58700
4.15%
Amgen IncAMGN6430
3.95%
Kailera Therapeutics IncKLRA170761
3.94%
Zealand Pharma A/SZEAL DC53593
3.69%
Ascletis Pharma Inc1672 HK1883000
3.40%
AstraZeneca PLCAZN12231
3.35%
Roche Holding AGROP SW4432
3.22%
MBX Biosciences IncMBX30701
3.03%
Hansoh Pharmaceutical Group Co Ltd3692 HK408000
2.96%
Innovent Biologics Inc1801 HK142000
2.58%
United Laboratories International Holdings Ltd/The3933 HK1488000
2.31%
Structure Therapeutics IncGPCR34453
2.09%
Gilead Sciences IncGILD8305
2.04%
Jiangsu Hengrui Pharmaceuticals Co Ltd1276 HK212000
1.82%
Gubra A/SGUBRA DC23057
1.48%
Rhythm Pharmaceuticals IncRYTM8906
1.39%
Shionogi & Co Ltd4507 JP43300
1.09%
First American Government Obligations Fund 12/01/2031FGXXX632248.73
0.69%
Wave Life Sciences IncWVE90052
0.18%
Cash & OtherCash&Other102497.67
-0.45%
SWISS FRANCCHF-215321.29